nitrosamines: where are we now?
Published 3 years ago • 3.1K plays • Length 23:53Download video MP4
Download video MP3
Similar videos
-
1:22:14
overview of the guidance for industry: control of nitrosamine impurities in human drugs
-
44:52
nitrosamine impurities-aug 2023 ndsris limit usfda guidance | control of nitrosamine guidance feb-21
-
0:49
19. mrna vaccines were developed based on decades of scientific study at nih...#fdafacts
-
18:11
nitrosamine impurities; what’s the impact on imps
-
44:22
which chemical is the worst carcinogen?
-
52:27
the meat lobby: inside the abyss of an industry | endevr documentary
-
3:16:41
tobacco products scientific advisory committee (tpsac) meeting p1— 6/26/2024
-
0:50
what are nitrosamines?
-
25:35
application of (q)sar and expert knowledge for ich m7 impurity classification
-
11:36
keynote: pharmaceutical quality: a global priority (cder) (1/15) global quality
-
1:03:32
why do we eat what we eat? neural and metabolic mechanisms of food choice
-
23:25
drug substance postapproval changes guidance: determination of impurity profile equivalence
-
2:23
tackling nitrosamine impurities in medicines
-
14:43
interview with naiffer romero at usp on nitrosamine impurities
-
5:35
#nationalnutday, celebrating the health benefits and delicious varieties of nuts
-
5:19
what is a nitrosamine? how is it formed?
-
1:12:17
regulatory best practices for global access to medicines including anti-tb medicines day 3-session 1
-
36:41
nitrosamine in pharmaceutical products? a deep dive into risk management by ron najafi, ph.d.
-
7:19
nitrosamine impurities || usfda guideline || part-1
-
18:10
sbia program overview - redi 2020
-
20:17
primary and secondary packaging as potential source of nitrosamines: impact on e&l study design
-
50:02
nitrosamines issue - a regulatory overview scientific webinar 2024